TEP AU 18-FDG ET TOXICITE NEUROLOGIQUE DES TRAITEMENTS ANTICANCEREUX

dc.contributor.advisorA. BELMEKKI
dc.contributor.authorLOUBNA AGOUZAL
dc.date.accessioned2023-09-15T13:39:15Z
dc.date.accessioned2026-01-22T13:32:24Z
dc.date.available2023-09-15T13:39:15Z
dc.date.issued2017
dc.description.collaboratorA. BELMEKKI
dc.description.collaboratorA. BIYI
dc.description.collaboratorA. FAOUZI
dc.description.collaboratorR. NEJJARI
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/18778
dc.identifier.urihttps://doi.org/10.83129/toubkal-12664
dc.language.isofr
dc.publisherUniversité Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabatfr_FR
dc.subjectTEP-TDM au 18-FDGfr_FR
dc.subjecttoxicité neurologiquefr_FR
dc.subjectanticancéreuxfr_FR
dc.subjectméthotrexatefr_FR
dc.subject.otherSciences médicales
dc.subject.specificMédecine nucléaire
dc.titleTEP AU 18-FDG ET TOXICITE NEUROLOGIQUE DES TRAITEMENTS ANTICANCEREUXfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
P0882017.pdf
Size:
2.48 MB
Format:
Adobe Portable Document Format